Comparison of peripheral and central biopsy sites for the isolation of Borrelia burgdorferi sensu lato from erythema migrans skin lesions

Clinical Infectious Diseases

Volumn 27, Issue 3, 1998, Pages 636-638

  Jurca, Tomaz ^a,b   Ruzic Sabljic, Eva ^a,b   Lotric Furlan, Stanka ^a,b   Maraspin, Vera ^a,b   Cimperman, Joze ^a,b   Picken, Roger N ^a,b   Strle, Franc ^a,b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BORRELIA BURGDORFERI; DISEASE ASSOCIATION; DISEASE CONTROL; ERYTHEMA CHRONICUM MIGRANS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT;

EID: 0031682598     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514715     Document Type: Article

References (12)

1. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-40.
2. Berger BW, Clemmensen OJ, Gottleb GJ. Spirochetes in lesions of erythema chronicum migrans. Am J Dermatopathol 1982;4:555-6.
3. Berger BW, Clemmensen OJ, Ackerman AB. Lyme disease is spirochetosis. Am J Dermatopathol 1983;5:111-24.
4. Neubert U, Krampitz HE, Engl H. Microbiological findings in erythema (chronicum) migrans and related disorders. Zbl Bakt Hyg A 1986; 263: 237-52.
5. Melski JW, Reed KD, Mitchell PD, Barth GD. Primary and secondary erythema migrans in central Wisconsin. Arch Dermatol 1993; 129:709-16.
6. Centers for Disease Control. Lyme disease surveillance-USA, 19891990. MMWR 1991;255:417-21.
7. Strle F, Preac-Mursic V, Cimperman J, Ruzic E, Maraspin V, Jereb M. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings. Infection 1993;21:83-8.
8. Preae-Mursic V, Wilske B, Schierz G. European Borrelia burgdorferi isolated from humans and ticks: culture conditions and antibiotic susceptibility. Zbl Bakt Hyg A 1986;263:112-8.
9. PDA Public Health Advisory. Assays for antibodies to Borrelia burgdorferi: limitations, use, and interpretation for supporting a clinical diagnosis of Lyme disease. Atlanta: U.S. Department of Health and Human Services, Public Health Service, 7 July 1997.
10. Wilske B, Preac-Mursic V. Microbiological diagnosis of Lyme borreliosis. In: Weber K, Burgdorfer W. Aspects of Lyme borreliosis. Berlin: Springer-Verlag, 1993:267-99.
11. Strie F, Nelson JA, Ruzic-Sabljic E, et al. European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clin Infect Dis 1996;23:61-5.
12. Picken MM, Picken RN, Han D, et al. A two year prospective study to compare culture and polymerase chain reaction amplification for the detection and diagnosis of Lyme borreliosis. Mol Pathol 1997; 50: 186-93.